Mounjaro® · Tirzepatide
Dual-action therapy for metabolic health
A once-weekly injection that activates GLP-1 and GIP receptors — supporting blood sugar balance and appetite control under licensed clinician supervision.
HIPAA CompliantLicensed PhysiciansFDA-Approved RxTelehealth Care
The Ongo difference
Physician-guided care, built around you
Weight loss support
GLP-1 therapy that works with your natural appetite signals for gradual, sustainable progress.
Medical guidance
Every patient is evaluated by a licensed clinician before any prescription is considered.
Personalized plans
Dosing schedules tailored to your tolerance, goals, and clinician recommendations.
Ongoing coaching
Care Team support from evaluation through delivery and beyond.
About Mounjaro
What is Mounjaro?
Mounjaro (tirzepatide) is a prescription medication FDA-approved for type 2 diabetes. It is the first dual GIP and GLP-1 receptor agonist, helping regulate blood sugar and appetite. Clinicians may consider it for weight management when medically appropriate.
See if you qualify →How it works
How does Mounjaro work?
Mounjaro activates both GLP-1 and GIP receptors — enhancing insulin response, slowing digestion, and reducing hunger signals. This dual mechanism supports metabolic health under ongoing clinician oversight.
Get Started Now →Your journey
Our step-by-step process
Complete your free online evaluation
Share your health history, goals, and BMI through our secure intake — takes about 5 minutes.
Meet with a licensed clinician
A board-certified provider reviews your case via telehealth and determines if Mounjaro is appropriate.
Receive your personalized plan
If prescribed, your clinician creates a titration schedule tailored to your tolerance and progress.
Medication delivered to your door
Your prescription ships discreetly from a licensed U.S. pharmacy with ongoing Care Team support.
Is Mounjaro right for you?
- Adults with type 2 diabetes or metabolic health needs
- Adults where a clinician determines tirzepatide may help
- Committed to lifestyle changes alongside medication
- No contraindications identified by your clinician
Safety
Important safety information
Common side effects
Nausea, diarrhea, decreased appetite, vomiting, and constipation — especially during dose escalation.
Serious risks
Thyroid tumor risk observed in rodents. Not for people with personal or family history of medullary thyroid carcinoma or MEN 2.
Do not use if
You are pregnant, breastfeeding, or allergic to tirzepatide or any Mounjaro ingredient.
Talk to your doctor
Mounjaro is not FDA-approved for weight loss alone. Your clinician evaluates risks and benefits before prescribing.
Clinical trial highlights
| Measure | Mounjaro | Placebo |
|---|---|---|
| Avg. weight change (72 weeks) | −22.5% | −2.0% |
| HbA1c reduction | Up to 2.4% | — |
| Patients losing ≥15% body weight | 36% | — |
*Based on SURMOUNT trial data. Mounjaro is FDA-approved for type 2 diabetes. Individual results vary.
Watch our Mounjaro overview
How to inject Mounjaro
- Wash hands and choose your injection site.
- Attach a new needle and check the pen flow if needed.
- Pinch skin, insert needle, and press until dose is delivered.
- Dispose of the needle safely and store the pen refrigerated.
Rotate injection sites weekly. Your clinician walks you through proper pen use.
AbdomenFront of thighUpper arm
Dosage & administration
Mounjaro is titrated gradually over several months. Your Ongo clinician personalizes the schedule.
- Weeks 1–4: 2.5 mg once weekly
- Weeks 5–8: 5 mg once weekly
- Weeks 9–12: 7.5 mg once weekly
- Further increases to 10 mg, 12.5 mg, or 15 mg per clinician guidance
Social proof
Patient testimonials
Real stories from patients on physician-guided Mounjaro care.
The appetite changes were noticeable within the first few weeks. Having a real doctor guide the dosing made me feel safe the whole way.
Sarah M.
Ongo patient · on Mounjaro
I appreciated that nobody rushed me. The evaluation was thorough, and my care team answered every question before I started.
James T.
4,000+Patients trust Ongo
Meet our medical team
Dr. Miller
Licensed Physician
Physician-guided weight loss and metabolic health consultations.
Dr. Niles
Board-Certified Physician
30+ years of clinical experience in patient-centered obesity care.
Dr. Krasne
Licensed Physician
Board-certified clinician focused on individualized treatment planning.
Dr. Bugailiskis
Board-Certified Physician
Evaluates patients based on health history, goals, and clinical needs.
Mounjaro is FDA-approved for type 2 diabetes. It may be prescribed off-label for weight management when a clinician determines it is medically appropriate.
Mounjaro activates both GIP and GLP-1 receptors (dual agonist), while Ozempic targets GLP-1 only. Your clinician recommends the best fit for your health profile.
Yes — if clinically appropriate after a licensed clinician evaluation.
Ready to see if Mounjaro is right for you?
Take a free evaluation. A licensed clinician will review your history and recommend a plan.
Get Started →Mounjaro® is a registered trademark of Eli Lilly and Company. Educational content only — not medical advice. Prescriptions issued when medically appropriate.